Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-1

E Stylianou1, J Saklatvala

  • 1School of Medical and Surgical Sciences, University Hospital, Queen's Medical Centre, Nottingham, UK. stylianou@nottingham.ac.uk

The International Journal of Biochemistry & Cell Biology
|October 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does decorin stabilize the extracellular matrix of articular cartilage and slow the progression of osteoarthritis?

Osteoarthritis and cartilage·2021
Same author

Skin bioengineering in the diagnosis of occupational protein contact dermatitis.

Occupational medicine (Oxford, England)·2020
Same author

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1<sup>+</sup> KLRG1<sup>-</sup> CD4<sup>+</sup> T cells.

Mucosal immunology·2018
Same author

Hypersensitivity reactions with prolonged infusions of β-lactams?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A.

Vaccine·2015
Same author

Transcriptional analysis of micro-dissected articular cartilage in post-traumatic murine osteoarthritis.

Osteoarthritis and cartilage·2014
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Interleukin 1 (IL1) regulates inflammation by activating protein kinases and transcription factors. Soluble IL1 receptor therapies show promise for reducing inflammatory responses.

Area of Science:

  • Immunology and Molecular Biology
  • Cellular signaling pathways in inflammation

Background:

  • Interleukin 1 (IL1) is a key mediator of inflammatory and immune responses.
  • IL1 signaling involves the type I receptor, activating kinases like NIK and MAP kinases.
  • These kinases modulate transcription factors (NF kappa B, AP1, CREB) controlling inflammatory genes.

Purpose of the Study:

  • To elucidate the downstream signaling pathways activated by Interleukin 1 (IL1) via its type I receptor.
  • To investigate the role of NIK and MAP kinase cascades in IL1-mediated gene regulation.
  • To assess the potential anti-inflammatory effects of targeting the IL1 pathway.

Main Methods:

  • Activation of protein kinases (NIK, MAP kinase cascades) by IL1 type I receptor.
  • Modulation of transcription factors including NF kappa B, AP1, and CREB.

Related Experiment Videos

  • Analysis of immediate early gene regulation central to the inflammatory response.

    • Main Results:

    • IL1 receptor activation leads to the activation of specific protein kinases.
    • Activated kinases modulate key transcription factors involved in inflammatory gene expression.
    • Phase I clinical trials suggest potential anti-inflammatory effects of soluble IL1 receptor and IRAP.

    Conclusions:

    • IL1 signaling pathways are critical for orchestrating inflammatory and immune responses.
    • Targeting the IL1 receptor pathway, potentially with soluble receptor or IRAP, may offer therapeutic anti-inflammatory strategies.